Chang Yi Wang Scientist
Chang Yi Wang (traditional Chinese: 王長怡; simplified Chinese: 王长怡), is an immunologist and astute organic chemist, best known for establishing a new platform in vaccines technology that employs designer peptide as key ingredients to be formulated into vaccines for the prevention and treatment of AIDS, HIV, Alzheimer disease, allergy and other emerging infectious diseases in both humans and animals. She is the founder of United Biomedical, Inc. (UBI) headquartered in Hauppauge, New York and its group of companies in Asia. Dr. Wang has served as Chief Scientific Officer of UBI since its inception in December 1985, and as Chairperson and Chief Executive Officer of the UBI Group of companies from 1998-2011. Dr. Wang is the author of over 120 peer-reviewed scientific publications and the inventor of over 100 patents to date. She has given various plenary lectures in the areas of Immunology, vaccination, immunotherapeutics and infectious diseases Infectious disease in many international conferences. She also serves on the scientific review committee for "Cooperative Research Partnerships for BioDefense" and “Allergy and Immunobiology” programs funded/administered by US National Institute of Health (NIH). In 2007, the New York Intellectual Property Law Association (NYIPLA) presented Dr. Wang with the US Inventor of the Year Award.
Search
Topical connections
Chang Yi Wang on Wikipedia
External resources
- http://www.thefreelibrary.com/United+Biomedical,+Inc.+and+Development+Fund,+Executive+Yuan+of+the...-a053048716
- http://www.unitedbiomedical.com